{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:53:42Z","timestamp":1767830022276,"version":"3.49.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/qai.0b013e3181b011f6","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T07:13:50Z","timestamp":1250752430000},"page":"17-24","source":"Crossref","is-referenced-by-count":20,"title":["Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment"],"prefix":"10.1097","volume":"52","author":[{"given":"Adriana","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Patterson-Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philimon","family":"Gona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne M","family":"Dankner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.inf.0000237830.33228.c3","article-title":"Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.","volume":"25","author":"Abzug","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jmv.1890460109","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men.","volume":"46","author":"Hess","year":"1995","journal-title":"J Med Virol"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/374562","article-title":"Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.","volume":"187","author":"Kemper","year":"2003","journal-title":"J Infect Dis"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0140-6736(04)16354-X","article-title":"Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.","volume":"363","author":"Mount","year":"2004","journal-title":"Lancet"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/516512","article-title":"Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men.","volume":"176","author":"Neilsen","year":"1997","journal-title":"J Infect Dis"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1086\/375841","article-title":"Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine.","volume":"37","author":"Rodriguez-Barradas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1055\/s-0038-1648904","article-title":"Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients.","volume":"72","author":"Santagostino","year":"1994","journal-title":"Thromb Haemost"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/424666","article-title":"Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.","volume":"39","author":"Wallace","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/592050","article-title":"Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.","volume":"198","author":"Rigaud","year":"2008","journal-title":"J Infect Dis"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1128\/JVI.00660-08","article-title":"Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection.","volume":"82","author":"Jiang","year":"2008","journal-title":"J Virol"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ni1302","article-title":"Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.","volume":"7","author":"Qiao","year":"2006","journal-title":"Nat Immunol"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.molimm.2006.07.302","article-title":"Direct impact of inactivated HIV-1 virions on B lymphocyte subsets.","volume":"44","author":"Viau","year":"2007","journal-title":"Mol Immunol"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","article-title":"Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.","volume":"103","author":"De Milito","year":"2004","journal-title":"Blood"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1073\/pnas.0730819100","article-title":"Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.","volume":"100","author":"Moir","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00002030-200105250-00003","article-title":"Loss of memory (CD27) B lymphocytes in HIV-1 infection.","volume":"15","author":"De Milito","year":"2001","journal-title":"AIDS"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.4049\/jimmunol.178.12.8212","article-title":"Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease.","volume":"178","author":"Hart","year":"2007","journal-title":"J Immunol"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1084\/jem.20032236","article-title":"Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.","volume":"200","author":"Moir","year":"2004","journal-title":"J Exp Med"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/aid.2007.0186","article-title":"A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individuals.","volume":"24","author":"Morrow","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood-2005-11-013383","article-title":"Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.","volume":"108","author":"Titanji","year":"2006","journal-title":"Blood"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V78.1.175.175","article-title":"A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest.","volume":"78","author":"Berberian","year":"1991","journal-title":"Blood"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"19436","DOI":"10.1073\/pnas.0609515103","article-title":"Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms.","volume":"103","author":"Ho","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1073\/pnas.0511094103","article-title":"Appearance of immature\/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.","volume":"103","author":"Malaspina","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1073\/pnas.181347898","article-title":"HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.","volume":"98","author":"Moir","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32828642c7","article-title":"Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.","volume":"21","author":"DOrsogna","year":"2007","journal-title":"AIDS"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/526789","article-title":"Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.","volume":"197","author":"Moir","year":"2008","journal-title":"J Infect Dis"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/319988","article-title":"Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy.","volume":"32","author":"Chen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00002030-200211080-00004","article-title":"Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy.","volume":"16","author":"Deayton","year":"2002","journal-title":"AIDS"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2249.2004.02583.x","article-title":"HIV-infected children with moderate\/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.","volume":"137","author":"Resino","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/498979","article-title":"Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.","volume":"193","author":"Weinberg","year":"2006","journal-title":"J Infect Dis"},{"key":"R31-3-20210131","first-page":"1","article-title":"A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"48","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00006454-199305000-00001","article-title":"Safety and immunogenicity of hepatitis A vaccine in healthy children.","volume":"12","author":"Horng","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/infdis\/171.Supplement_1.S50","article-title":"Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.","volume":"171","author":"Sandman","year":"1995","journal-title":"J Infect Dis"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jmv.1890440425","article-title":"Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.","volume":"44","author":"Van Damme","year":"1994","journal-title":"J Med Virol"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<235::AID-JMV13>3.0.CO;2-B","article-title":"Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.","volume":"49","author":"Wiens","year":"1996","journal-title":"J Med Virol"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e318183a9c0","article-title":"Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.","volume":"49","author":"Launay","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine.","volume":"139","author":"Levin","year":"2001","journal-title":"J Pediatr"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2008.05.054","article-title":"Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.","volume":"26","author":"Levin","year":"2008","journal-title":"Vaccine"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/433180","article-title":"Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons.","volume":"41","author":"Overton","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R40-3-20210131","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/590215","article-title":"Pediatric human immunodeficiency virus infection and circulating IgD+ memory B cells.","volume":"198","author":"Jacobsen","year":"2008","journal-title":"J Infect Dis"},{"key":"R41-3-20210131","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2005.06.022","article-title":"Cell mediated and antibody immune response to inactivated hepatitis A vaccine.","volume":"23","author":"Schmidtke","year":"2005","journal-title":"Vaccine"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200909010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:25:09Z","timestamp":1618039509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200909010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181b011f6","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}